PedAM
Pediatric Disease Annotations & Medicines
| Disease | pulmonary hypertension |
| Phenotype | C0018799|heart disease |
| Sentences | 69 |
| PubMedID- 26261613 | Objective: to investigate the relationship between p-selectin gene polymorphism and congenital heart disease (chd) with pulmonary hypertension (pah). |
| PubMedID- 24999252 | Background: pulmonary hypertension (ph) associated with left heart disease (world health organization [who] group ii) has previously been linked with significant morbidity and mortality. |
| PubMedID- 21069290 | Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease. |
| PubMedID- 22748905 | pulmonary hypertension associated with left-sided heart disease. |
| PubMedID- 24037633 | pulmonary hypertension associated with left heart disease. |
| PubMedID- 20450852 | In addition, it contains detailed descriptions of the treatment recommended for patients in whom an elevated systolic pulmonary pressure is discovered on echocardiography, of the differential diagnosis of pulmonary arterial hypertension and pulmonary hypertension associated with left heart disease, and of multifactorial approaches to determining prognosis, which are three of the most actively debated topics today. |
| PubMedID- 22494051 | Introduction and objective: the present study aims to quantitatively evaluate the right ventricle (rv) function by means of transthoracic echocardiography in normal children and childhood congenital heart disease patients with pulmonary hypertension. |
| PubMedID- 20494465 | Lung biopsy findings in previously inoperable patients with severe pulmonary hypertension associated with congenital heart disease. |
| PubMedID- 20646560 | [the actuarial survival analysis to the surgical and non-surgical therapy regime for congenital heart disease with severe pulmonary hypertension]. |
| PubMedID- 20646483 | [surgical treatment strategies for congenital heart disease with pulmonary hypertension]. |
| PubMedID- 23932041 | Objectives: the two hemodynamic profiles in left heart disease (lhd) with pulmonary hypertension (ph), passive ph with increased pulmonary venous pressure and reactive ph with increased pulmonary vascular resistance (pvr > 3 wood units, wu), are difficult to distinguish non-invasively. |
| PubMedID- 24987253 | The clinical characteristics of the study population including the referral diagnosis are listed in table 1. ventricular septal defect (vsd) was the most common congenital heart disease leading to pulmonary hypertension in this study. |
| PubMedID- 20814475 | The introduction of inhaled nitric oxide (ino) has added a new dimension to the treatment of pulmonary hypertension associated with congenital heart disease. |
| PubMedID- 25737007 | Asymmetric dimethyl-l-arginine is a biomarker for disease stage and follow-up of pulmonary hypertension associated with congenital heart disease. |
| PubMedID- 23258775 | High prevalence of occult left heart disease in scleroderma-pulmonary hypertension. |
| PubMedID- 25089008 | Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated nt-probnp levels or overt cardiac fibrosis but associated with increased levels of mr-proanp and mr-proadm: retrospective analysis of a french canadian cohort. |
| PubMedID- 25705389 | Current classification describes five main groups with shared clinical and pathophysiological characteristics (figure 1): group 1, pah; group 2, pulmonary hypertension associated with left heart disease; group 3, pulmonary hypertension associated with lung disease; group 4, chronic thromboembolic pulmonary hypertension (cteph); and group 5, miscellaneous with unclear mechanisms [2]. |
| PubMedID- 22169723 | Objective: to explore the effect of unidirectional valved patch (uvp) for congenital heart disease (chd) with severe pulmonary hypertension (ph). |
| PubMedID- 25650280 | [pulmonary hypertension associated with congenital heart disease and eisenmenger syndrome]. |
| PubMedID- 26262457 | Recent findings: the current focus on better defining the underlying pathophysiology and standardizing diagnostic and therapeutic approaches to pulmonary hypertension associated with left heart disease need to be interpreted and made applicable in the context of clinical practice. |
| PubMedID- 25076994 | The pivotal super trial demonstrated that sildenafil therapy causes an improvement in the 6mwd in patients with ipah and ctd-apah or pulmonary hypertension associated with repaired congenital heart disease (patients were predominantly fc ii or iii) at all three doses tested (20, 40, and 80 mg, given three times a day). |
| PubMedID- 24771555 | The majority had idiopathic pulmonary arterial hypertension (n=30); the remaining patients had pulmonary hypertension associated with repaired congenital heart disease (n=17) or lung disease (n=3). |
| PubMedID- 23559349 | There has been no established medical therapy to ameliorate pulmonary hypertension (ph) owing to left heart disease (lhd-ph). |
| PubMedID- 23154245 | Thus, we diagnosed pulmonary hypertension owing to left heart disease and complete atrioventricular block that resulted from hcq toxicity. |
| PubMedID- 23075130 | pulmonary hypertension associated with congenital heart disease: a practical review for the pediatric cardiologist. |
| PubMedID- 22870905 | Furthermore, l-citrulline decreased pulmonary hypertension after surgery in patients with congenital heart disease [47], and it also reduced blood pressure response to cold stress [48]. |
| PubMedID- 22526220 | Elevated homocysteine and asymmetric dimethyl arginine levels in pulmonary hypertension associated with congenital heart disease. |
| PubMedID- 24889436 | Our top five recommendations, which were approved by the executive committees of the ats and american college of chest physicians and published by choosing wisely in october 2013, are as follows: (1) do not perform ct scan surveillance for evaluation of indeterminate pulmonary nodules at more frequent intervals or for a longer period of time than recommended by established guidelines; (2) do not routinely offer pharmacologic treatment with advanced vasoactive agents approved only for the management of pulmonary arterial hypertension to patients with pulmonary hypertension resulting from left heart disease or hypoxemic lung diseases (groups ii or iii pulmonary hypertension); (3) for patients recently discharged on supplemental home oxygen following hospitalization for an acute illness, do not renew the prescription without assessing the patient for ongoing hypoxemia; (4) do not perform chest ct angiography to evaluate for possible pulmonary embolism in patients with a low clinical probability and negative results of a highly sensitive d-dimer assay; (5) do not perform ct scan screening for lung cancer among patients at low risk for lung cancer. |
| PubMedID- 25981561 | Plasma levels of acylated ghrelin in children with pulmonary hypertension associated with congenital heart disease. |
| PubMedID- 24561861 | Patients with pulmonary hypertension associated with congenital heart disease survive longer with preserved right ventricular (rv) function compared with those with primary pulmonary hypertension. |
| PubMedID- 24267298 | pulmonary hypertension owing to left heart disease. |
| PubMedID- 26232475 | Pulmonary arterial hypertension or left heart disease with pulmonary hypertension. |
| PubMedID- 23130100 | [19] this regression is not observed in patients with congenital heart disease associated with pulmonary hypertension, which may contribute to their relatively good outcome compared to patients with pah. |
| PubMedID- 26471823 | There are several mechanisms of pulmonary hypertension in patients with adult congenital heart disease, and understanding them requires a systematic approach to define the patient's hemodynamics and physiology. |
| PubMedID- 22313804 | Clinical significance of reactive post-capillary pulmonary hypertension in patients with left heart disease. |
| PubMedID- 26559982 | Palliative senning in the treatment of congenital heart disease with severe pulmonary hypertension. |
| PubMedID- 24081196 | The effects of perioperative inhaled iloprost on pulmonary hypertension with congenital heart disease. |
| PubMedID- 23351920 | Long-term effect of bosentan in pulmonary hypertension associated with complex congenital heart disease. |
| PubMedID- 24075485 | Sivelestat attenuates lung injury in surgery for congenital heart disease with pulmonary hypertension. |
| PubMedID- 22837863 | Indeed, in murine models of pulmonary hypertension associated with left heart disease and in monocrotaline-induced rodent pulmonary hypertension, treatment with a mast cell stabilizer or use of mast cell deficient rats attenuated vascular remodeling. |
| PubMedID- 21712881 | pulmonary hypertension, with congenital heart disease, is seen in large systemic-to-pulmonary communications, such as ventricular septal defect (vsd) and patent ductus arteriosus. |
| PubMedID- 23098893 | We investigated the occurrence of bmpr2 mutation and genetic polymorphisms in children with pulmonary hypertension associated with congenital heart disease (aph/chd) and correlated with the pulmonary haemodynamic and vasoreactivity. |
| PubMedID- 20522580 | pulmonary hypertension associated with congenital heart disease: pulmonary vascular disease: the global perspective. |
| PubMedID- 26203294 | The more frequent cardiac conditions of this group are:chronic left heart diseases with secondary pulmonary hypertension (group 2 of pulmonary hypertension classification10). |
| PubMedID- 24141893 | Congenital heart disease was the etiology of pulmonary hypertension in the majority of cases (n = 33) and 28 patients were in nyha functional class iii-iv. |
| PubMedID- 21769595 | Perioperative management of pulmonary hypertension in children with critical heart disease. |
| PubMedID- 20459681 | 3 years old female patient, known case of congenital heart disease with pulmonary hypertension and cerebral palsy was admitted to the hospital on 7th october 2009 with high grade of fever, cough, sore throat, difficulty in breathing and body aches. |
| PubMedID- 21875514 | pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies. |
| PubMedID- 20924360 | pulmonary hypertension with left-sided heart disease. |
| PubMedID- 23890862 | Long-term effects of continuous prostacyclin therapy in adults with pulmonary hypertension associated with congenital heart disease. |
Page: 1 2